BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 21, 2024
See today's BioWorld
Home
» Other news to note for March 2, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for March 2, 2021
March 2, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aardvark, Abbvie, Abionyx, Adimab, Adverum, Agex, Agonox, Altaris Capital, Arsanis, Artizan, Astrazeneca, Awakn, Beactica, Biohaven, Cynata, Eli Lilly, Esperion, Fusion, Gore, Haisco, HWC, Iktos, Ipsen, Innovation, Junshi, Kiniksa, Lidds, Lygenesis, Maverick, Merck, Mitokinin, Nanoviricides, Novartis, Oncosec, Oscotec, Perrigo, Pfizer, Phio, Presage, PYC, Q Biomed, Qualigen, Rallybio, Sorrento, Starton, Strata Tauriga, Verisim, Viacyte, Vyne, Wugen, Yuyu.
BioWorld
Briefs
Other news to note
Coronavirus